Search

28 Apr 2022: and Macmillan Cancer Support, in order to define a new clinical pathway for treating suspected neutropenic sepsis, and to ensure people living with disease continue to be at the heart of

11 Apr 2022: investment. Less than five years later, we again released news about the company. ... This time, however, the news was the completion of a $9.5 million Series A funding round.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131H as a transmembrane protein with its native intracellular domain.

23 Mar 2022: Insights from Tenyks help engineers accelerate their development lifecycle, so they spend less time onboarding new users, reducing customer acquisition costs, and boosting the accuracy of AI. ... Moreover, future new deployments can be onboarded in half

9 May 2022: Hybridoma cell line producing YTH 54.12 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

14 Jun 2022: Share:. Spirea Limited, a University of Cambridge spin-out company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has secured funding of £2.4 million. ... We welcome our new investors and thank our existing investors

9 May 2022: CHO cells transfected to express human FcgRllb allotype 131R as a transmembrane protein with its native intracellular domain.

22 Mar 2022: When Cambridge Enterprise was looking to make a film about Consultancy Services, Dr Hugh Hunt, Cambridge University Reader in Engineering Dynamics and...

8 Mar 2022: Even in new construction, it is important to ensure safe environments and understand the short- and long-term environmental impact of a site. ... The proliferation of new sensors and satellite technology has the potential to fuel a revolution in

9 May 2022: Hybridoma cell line producing YFC118.12 antibodies raised against human CD18 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: impact of this course is enormous, and we will continue working with the University of Cambridge and the 3C Programme consortium to exploit new mechanisms for collaboration and mutual learning.

9 May 2022: Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are rat monoclonal antibodies of the IgG2b isotype.

8 Mar 2022: Cambridge spin-out DIOSynVax will receive $42 million to develop a vaccine candidate to protect against existing and future variants of SARS-CoV-2.

9 May 2022: Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: This limited visibility is an even bigger problem for SMEs. Providing an effective, new way to cut these losses offers a huge commercial opportunity. ... Mining millions of words in news articles, business reports, and social media posts, Versed AI’s

31 May 2022: The round, led by H&M Group via investment arm H&M CO:LAB, includes existing investor, Sagana, as well as new investors Bombyx Growth Fund, PDS Ventures, Regeneration.VC and

9 May 2022: Hybridoma cell line producing YTH 71.3 antibodies raised against human CD66acd which are rat monoclonal antibodies of the IgG2a isotype.

11 Apr 2022: Our consultancy services team supported Department of Chemical Engineering and Biotechnology researchers in testing anti-viral materials.

8 Nov 2022: Carbon Re’s platform, in contrast, is already reducing emissions today, cuts the cost of production, and requires no new equipment. ... The new investment will enable product roll-out into the global cement market and expand into other energy-intensive

9 May 2022: Hybridoma cell line producing YTH 80.103 antibodies raised against human CD45R which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTH 906.9HL antibodies raised against human CD25 which are rat monoclonal antibodies of the IgG2b isotype.

4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard

9 May 2022: Hybridoma cell line producing YW 62.3.20 antibodies raised against mouse CD45 which are rat monoclonal antibodies of the IgG2b isotype.

20 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 20 September 2022. Cambridge Enterprise, Cambridge Innovation Capital, and University launch Innovate Cambridge. Share:. Cambridge Enterprise, Cambridge Innovation Capital, and the

9 May 2022: Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which are monoclonal antibodies of the IgG2a isotype.

9 May 2022: JBIG-KIT software library is an implementation of the JBIG1 data compression standard (ITU-T T.82), which was designed for bi-level high-resolution image data.

8 Dec 2022: Innovate Cambridge’s founders, new steering committee and charter signatories will now begin to define an ambitious, inclusive vision for the greater Cambridge area. ... A constant source of new ideas and innovations, the Cambridge innovation ecosystem

9 May 2022: KARPAS 1718 Human Splenic Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158F allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.

9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158V allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.

9 May 2022: Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mouse monoclonal antibodies.

9 May 2022: Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are rat monoclonal antibodies of the IgG2a isotype.

9 May 2022: KARPAS 45 Human T-cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 353 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 231 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YBM 29.2.1antibodies raised against mouse Thy-1, which are rat monoclonal antibodies of the IgG2c isotype.

9 May 2022: Sharp graphite tips have been developed in the lab of Dr Amalio Fernandez-Pacheco at the University of Cambridge using a three-step polishing method.

9 May 2022: Tetrabutylammonium (4'methyl-[2,2'bipyridin]-5yl)methanesulfonate is a ligand for iridium to control regioselectivity of iridium-catalysed borylation

9 May 2022: Hybridoma cell line producing SIg 375 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 482 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 743 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR CT-1 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 83-7 antibodies raised against the human insulin receptor, which are mouse monoclonal antibodies of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR CT-3 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 47-9 antibodies raised against the alpha subunit of the human insulin receptor,which are monoclonals of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-45 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-43 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-42 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2b isotype.